Featured Jobs
|
Retirement Plan Consultants
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
MAP Retirement
|
|
BPAS
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
Pentegra
|
|
Southern Pension Services
|
|
Retirement Relationship Manager MAP Retirement
|
|
BPAS
|
|
July Business Services
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Anchor 3(16) Fiduciary Solutions
|
|
Compass
|
|
BPAS
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Individual Patient's Genes May Affect Which GLP-1 Obesity Drugs Work Best
BenefitsPro; registration may be required 
June 12, 2025 "Knowing which works better is critical for employers' health plans, because anti-obesity drugs now account for about 17% of U.S. employer health plan prescription spending ... The full retail price of the drugs is about $1,400 per month for Victoza; $1,500 per month for Wegovy, a better-known drug that's similar to Victoza; and just $200 per month for Qsymia." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |